Get Your Assay In Gear - Removing Analytical Bottlenecks On The Path To Clinical Readiness

Many cellular therapy candidates are advancing rapidly toward clinical-stage manufacturing. However, some are experiencing delays due to the absence of high-quality analytical methods. To address this issue, Miltenyi Biotec is prioritizing the standardization and automation of analytical characterization technologies. This strategic focus aims to enhance the efficiency and reliability of in-process control (IPC) and quality control (QC) for cellular therapies to ensure a more streamlined and effective development process.